Correlation Between Spire Global and Ascelia Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spire Global and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spire Global and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spire Global and Ascelia Pharma AB, you can compare the effects of market volatilities on Spire Global and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spire Global with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spire Global and Ascelia Pharma.

Diversification Opportunities for Spire Global and Ascelia Pharma

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Spire and Ascelia is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Spire Global and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and Spire Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spire Global are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of Spire Global i.e., Spire Global and Ascelia Pharma go up and down completely randomly.

Pair Corralation between Spire Global and Ascelia Pharma

Given the investment horizon of 90 days Spire Global is expected to generate 1.05 times more return on investment than Ascelia Pharma. However, Spire Global is 1.05 times more volatile than Ascelia Pharma AB. It trades about 0.31 of its potential returns per unit of risk. Ascelia Pharma AB is currently generating about 0.31 per unit of risk. If you would invest  1,091  in Spire Global on September 4, 2024 and sell it today you would earn a total of  386.00  from holding Spire Global or generate 35.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Spire Global  vs.  Ascelia Pharma AB

 Performance 
       Timeline  
Spire Global 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Spire Global are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating forward indicators, Spire Global reported solid returns over the last few months and may actually be approaching a breakup point.
Ascelia Pharma AB 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, Ascelia Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Spire Global and Ascelia Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spire Global and Ascelia Pharma

The main advantage of trading using opposite Spire Global and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spire Global position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.
The idea behind Spire Global and Ascelia Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance